NCT04315064 Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma Status COMPLETED Phase EARLY_PHASE1
NCT04270461 NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors Status WITHDRAWN Phase PHASE1
NCT04081701 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. Status RECRUITING Phase PHASE4
NCT04049669 Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04023669 Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors Status COMPLETED Phase PHASE1
NCT03990597 StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord Status WITHDRAWN Phase PHASE1
NCT03904862 Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Status TERMINATED Phase PHASE1/PHASE2
NCT03734913 A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03709680 Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03638167 EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors Status COMPLETED Phase PHASE1
NCT03500991 HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03434262 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Status COMPLETED Phase PHASE1
NCT03389802 Phase I Study of APX005M in Pediatric Central Nervous System Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03273712 Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) Status COMPLETED Phase PHASE2
NCT03257631 A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors Status COMPLETED Phase PHASE2
NCT03173950 Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers Status COMPLETED Phase PHASE2